Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients

Transplantation

Volumn 94, Issue 6, 2012, Pages 630-636

  Orcurto, Angela ^a   Pascual, Manuel ^a   Hoschler, Katja ^b   Aubert, Vincent ^a   Meylan, Pascal ^a   Manuel, Oriol ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Basiliximab; Organ transplantation; Prevention; Thymoglobulin

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CD4 ANTIGEN; CREATININE; CYCLOSPORIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGE; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; FATIGUE; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INJECTION SITE INDURATION; INJECTION SITE REACTION; INJECTION SITE REDNESS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA; PRIORITY JOURNAL; RISK ASSESSMENT; SEASONAL INFLUENZA; SEROCONVERSION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS HEMAGGLUTINATION; VIRUS STRAIN;

ADULT; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CHI-SQUARE DISTRIBUTION; FEMALE; GRAFT REJECTION; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTINATION, VIRAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; RECOMBINANT FUSION PROTEINS; RISK ASSESSMENT; RISK FACTORS; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; VACCINATION;

EID: 84866731808     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31825f7f82     Document Type: Article

References (27)

1. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 28-7.
2. Smud A, Nagel CB, Madsen E, et al. Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation 2010; 90: 145-8.
3. Kumar D, Blumberg EA, Danziger-Isakov L, et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant 2011; 11: 202-0.
4. Crespo M, Collado S, Mir M, et al. Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol 2011; 6: 220-8.
5. Manuel O, Humar A, Berutto C, et al. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant 2011; 30: 67-9.
6. Manuel O, Pascual M, Hoschler K, et al. Humoral response to the influenza A H1N1/09 monovalent AS03-Adjuvanted vaccine in immunocompromised patients. Clin Infect Dis 2011; 52: 24-8.
7. Scharpé J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8: 33-2.
8. Smith KG, Isbel NM, Catton MG, et al. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998; 13: 16-0.
9. Padiyar A, Augustine JJ, Hricik DE. Induction antibody therapy in kidney transplantation. Am J Kidney Dis 2009; 54: 93-5.
10. Brennan DC, Schnitzler MA. Long-Term results of rabbit antithymocyte globulin and basiliximab induction. New Engl J Med 2008; 359: 173-6.
11. Manuel O, Venetz JP, Fellay J, et al. Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolatebased regimen in kidney transplantation. SwissMedWkly 2007; 137: 66-9.
12. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 271-5.
13. Sageshima J, Ciancio G, Guerra G, et al. Prolonged lymphocyte depletion by single-dose rabbit anti-Thymocyte globulin and alemtuzumab in kidney transplantation. Transpl Immunol 2011; 25: 10-4.
14. Salles MJ, Sens YA, Boas LS, et al. Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplant 2010; 24: E1-7.
15. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10: 52-1.
16. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9: 49-3.
17. Manuel O, Humar A, Chen MH, et al. Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant 2007; 7: 256-7.
18. Keshtkar-Jahromi M, Argani H, Rahnavardi M, et al. Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol 2008; 28: 65-4.
19. Broeders EN, Wissing KM, Hazzan M, et al. Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: association with infectious complications. Transpl Int 2008; 21: 5-7.
20. Boddana P, Webb LH, Unsworth J, et al. Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetilYtreated renal transplant recipients: an emerging clinical phenomenon? Clin Transplant 2011; 25: 41-7.
21. Munoz P, Giannella M, Alcalá L, et al. Clostridium difficileYassociated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer? J Heart Lung Transplant 2007; 26: 90-7.
22. Doron S, Ruthazer R, Werner BG, et al. Hypogammaglobulinemia in liver transplant recipients: incidence, timing, risk factors, and outcomes. Transplantation 2006; 81: 69-7.
23. Sasaki Y, Kusuhara K, Saito M, et al. Serum immunoglobulin levels do not affect antibody responses to influenza HA vaccine in preterm infants. Vaccine 2006; 24: 220-8.
24. Pedersen G, Halstensen A, Sjursen H, et al. Pandemic influenza vaccination elicits influenza-specific CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports. Scand J Immunol 2011; 74: 21-0.
25. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 75-3.
26. Ellis JS, Zambon MC. Molecular analysis of an outbreak of influenza in the United Kingdom. Eur J Epidemiol 1997; 13: 36-9.
27. European Agency for the Evaluation of Medicinal Products/Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonization of requirements for influenza vaccines. London, England; 1997. Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500003945.pdf. Accessed August 13, 201-2.